Wortmannin and LY294002 are both inhibitors of the PI3K/Akt signaling pathway, commonly associated with cellular processes like growth and proliferation. They function by obstructing the pathway's signal transduction, which could suppress the activity of proteins downstream, such as LOC728546, assuming it is dependent on PI3K/Akt for its function. Rapamycin is another inhibitor with a distinct target; it inhibits mTOR, a central molecule in cell growth and protein synthesis regulation. This inhibition can lead to a reduction in cellular processes that rely on mTOR signaling, potentially including those involving LOC728546.
Similarly, MEK inhibitors like PD98059 and U0126 selectively block the MAPK/ERK pathway, which is pivotal in cell division and differentiation. By inhibiting this pathway, they could indirectly affect proteins regulated by it. In the realm of stress response and inflammation, SB203580 acts on p38 MAPK, and SP600125 targets the JNK pathway, both of which could modify the activity of proteins involved in these pathways, possibly including LOC728546. On the front of cell survival and proliferation, PP2 and Dasatinib are known to inhibit Src family kinases. These kinases are integral to numerous cellular functions, including cell migration and angiogenesis. Inhibition by these chemicals could thus have far-reaching effects on any associated protein's activity, such as LOC728546, if it were to be involved in similar cellular functions. ZM-447439, an Aurora kinase inhibitor, affects cell cycle progression and division, offering potential modulation of proteins like LOC728546 if they are implicated in these processes. Gefitinib targets the EGFR tyrosine kinase and can disrupt processes like cell proliferation, which could have downstream effects on proteins involved in the EGFR pathway. Lastly, 2-Deoxy-D-glucose, a glycolysis inhibitor, can induce energy stress in cells and interfere with metabolic functions, potentially impacting proteins that are sensitive to cellular energy levels, including LOC728546 if it plays a role in energy metabolism.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor that impedes the PI3K/Akt pathway, potentially reducing the activity of downstream proteins including LOC728546 if it is PI3K/Akt dependent. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor that can block the PI3K/Akt signaling, possibly affecting LOC728546 if it is part of this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor that can decrease protein synthesis and cell proliferation, which may influence LOC728546 if it is involved in mTOR signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor that can impede the MAPK/ERK pathway, possibly affecting LOC728546 activity if it is regulated by this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor that can disrupt inflammatory responses and cell differentiation, potentially affecting LOC728546. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that can modulate apoptosis and cell proliferation, possibly influencing LOC728546 if it is JNK associated. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
MEK1/2 inhibitor that can block the MAPK/ERK pathway, potentially modulating LOC728546 if it is associated with this pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Src family kinase inhibitor that can affect cell survival and proliferation, potentially affecting LOC728546 if it involves Src signaling. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
Aurora kinase inhibitor that can affect cell division, which may influence LOC728546 if it is involved in cell cycle regulation. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Src family tyrosine kinase inhibitor that can impede cell growth and survival, potentially affecting LOC728546 if it is part of these signaling routes. | ||||||